February 27, 2021
Business News

JS Bio and Etta Biotech Advancing Strategic Partnership


THOUSAND OAKS, Calif. & SHANGHAI–()–Jianshun Biosciences Co., Ltd. (“JS Bio”) recently announced its strategic partnership with Etta Biotech Co., Ltd. (“Etta Biotech”), to set up a high titer transient protein expression platform for high quality protein production using JS Bio’s transient transfection media. JS Bio becomes the exclusive cell culture supplier for Etta Biotech’s transient transfection high titer protein expression platform.

Etta Biotech is a leading cell electroporation technology and equipment supplier. Its proprietary large-capacity flow electroporator, X-Porator F1, is one of the only two products of its kind in the world, and leads the market with its outstanding performance and…



Click here to view the original article.

Related Posts

You might also like ...

AVer Europe: How to Prepare for Hybrid Workspaces
Sixpoint Partners Serves as Exclusive Placement Agent for CORE Industrial Partners Fund II
TEST EW 2021 FEB 27 TEST